Consistent with the conclusions of our study, GRIA1, GRIN2A, and SLC17A6 expressions were more upregulated in patients with PDD than in those with DLB, further genetically explaining the cognitive dysfunction is graver in patients with DLB than in those with PDD. The gene discussed is GRIN2A; the disease is Lewy body dementia.